Outcome of Board Meeting

Vikas Lifecare Limited ( A NSE / BSE Listed Company ) CIN : L25111DL1995PLC073719 Web : www.vikaslifecarelimited.com Email : info@vikaslifecarelimited.com Tel. : +91-11-40450110 June 24, 2026 Listing Compliance Department Listing Compliance Department National Stock Exchange of India Limited. BSE Limited. Exchange Plaza, Phirozee Jeejeebhoy Bandra-Kurla Complex, Towers, Dalal Street, Fort, Bandra (E), Mumbai 400051 Mumbai - 400 001 NSE Symbol: VIKASLIFE Scrip Code: 542655 Sub: Outcome of Board Meeting held on 24th June, 2026 Dear Sir/Madam, Pursuant to Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., June 24, 2026, has, inter alia, considered and approved the following: Audited Financial Results for the Quarter and Financial Year ended March 31, 2026 The Board has approved the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026, and pursuant to Regulation 33 of the SEBI Listing Regulations, please find enclosed the Auditor’s Report on the Audited Financial Results and the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026. The meeting of the Board of Directors commenced at 06:20 P.M. and concluded at 10:10 P.M. We request you to kindly the information on record and oblige. Thanking you, Yours Faithfully, for Vikas Lifecare Limited Sundeep Kumar Dhawan Managing Director (DIN: 09508137) Regd. Office : Vikas House, 3, Arihant Nagar, Rohtak Road, Punjabi Bagh West, Delhi 110026 Factory I : G-83,Vigyan Nagar,RIICO Indl. Area, Shahjahanpur, Dist. Alwar, Rajasthan – 301706 Factory II : Plot No. 193, Revenue Survey No. 93, Baikampady, Dist. Dakshina Kannada, Mangaluru, Karnataka - 575011 INDEPENDENT AUDITOR’S REPORT ON STANDALONE FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF VIKAS LIFECARE LIMITED Qualified Opinion We have audited the accompanying Statement of Standalone Financial Results of VIKAS LIFECARE LIMITED (the “Company”), for the quarter and year ended March 31, 2026 (the “Statement”), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). In our opinion and to the best of our information and according to the explanations given to us, except for the possible effects of the matters described in the paragraph “Basis for Qualified Opinion” section of our report, the aforesaid standalone financial results: a. are presented in accordance with the requirements of Regulation 33 and Regulation 52 of the Listing Regulations in this regards; and b. gives a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Accounting Standard prescribed under Section 133 of the Companies Act 2013 (the“Act”) and other accounting principles generally accepted in India, of the net profit and comprehensive loss and other financial information of the Company for the quarter ended and year ended March 31, 2026. Basis for Qualified Opinion 1. During the year, there were certain delays in the deposit of statutory dues by the Company. While some substantial statutory dues remained outstanding, the Company continued its business and investment activities, including investments in shares and granting of inter-corporate deposits during the year. We were not provided sufficient appropriate audit evidence with respect to business rationale of such investments and deposits and hence in view of this, we are unable to determine the impact of the said matters on the accompanying audited financial results. 2. During the year ending 31st March 2026, the Company has entered into related party transactions, inter alia, in the nature of inter-corporate deposits, acquisition of investments and other transactions with its promoter group entities, subsidiaries including step down subsidiaries and/or associates and other parties which are considered material related party transactions in accordance with the provisions of Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”). Such transactions are also subject to compliance with the applicable provisions of Section 188 of the Companies Act, 2013 and other applicable provisions, if any. As per the applicable provisions of the Companies Act, 2013 and Regulation 23 of the SEBI LODR Regulations, prior approval of the shareholders, wherever applicable, is required for such transactions. As represented to us, the Company is in the process of obtaining the requisite approvals for the aforesaid transactions, which had not been obtained up to the date of approval of these financial results. Accordingly, we are unable to determine the impact, if any, of the above matter, including the consequential implications arising from non-compliance with the applicable regulatory requirements, if any, on the accompanying financial results. We conducted our audit of the Statement in accordance with the Standards on Auditing (“SA”s) specified under Section 143(10) of the Act and other applicable authoritative pronouncements issued by Institute of Chartered Accountant of India. Our responsibilities under those Standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Results section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (“ICAI”) together with the ethical requirements that are relevant to our audit of the Financial Results under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI’s Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our audit opinion. Emphasis of Matters 1. Settlement of Debenture Transactions We draw attention to Note 8 to the financial results regarding the Company's transactions for acquisition of debentures aggregating to ₹52.00 crore from Hallow Securities Private Limited ("HSPL"). As disclosed in the said note, the balance outstanding from HSPL as at 31 March 2026 remains unconfirmed and no independent balance confirmation has been received by the Company from HSPL up to the date of approval of these financial results. Further, subsequent to the reporting date, the Company entered into a Settlement Agreement dated 30 May 2026 with HSPL, whereby the parties agreed to settle the principal amount of ₹52.00 crore and an additional compensation of ₹3.00 crore was agreed to be paid to the Company. Based on the terms of the Settlement Agreement, receipt of part payments subsequent to the reporting date and management's assessment of recoverability, the aforesaid financial asset has been considered recoverable and no impairment provision has been recognised in respect thereof. The additional lumpsum compensation of ₹3.00 crore has not been recognised in the financial results for the year ended 31 March 2026 as the right to receive the same arose subsequent to the reporting date. 2. Investment in Ebix International Holdings Limited arising pursuant to Settlement with Eraaya Lifespaces Limited (ELL) We draw attention to Note 9 to the accompanying financial results which describes that during the previous year, Eraaya Lifespaces Limited (“ELL”) had acquired the Ebix Inc and its global subsidiaries pursuant to Chapter 11 proceedings under the supervision of the Dallas Court, U.S. As further detailed in the said note, Vikas Lifecare Limited (“VLL”), as part of the consortium led by ELL, had contributed INR 2,977.27 million (equivalent [Showing first 8,000 characters — download PDF for full document]